Pular para o conteúdo
Merck
Todas as fotos(1)

Documentos Principais

PHR1071

Supelco

Ácido cítrico

Pharmaceutical Secondary Standard; Certified Reference Material

Sinônimo(s):

Citric acid

Faça loginpara ver os preços organizacionais e de contrato

Selecione um tamanho

1 G
R$ 548,00

R$ 548,00


Em estoqueDetalhes


Solicite uma grande encomenda

Selecione um tamanho

Alterar visualização
1 G
R$ 548,00

About This Item

Fórmula linear:
HOC(COOH)(CH2COOH)2
Número CAS:
Peso molecular:
192.12
Beilstein:
782061
Número CE:
Número MDL:
Código UNSPSC:
41116107
eCl@ss:
39021801
ID de substância PubChem:
NACRES:
NA.24

R$ 548,00


Em estoqueDetalhes


Solicite uma grande encomenda

grau

certified reference material
pharmaceutical secondary standard

Nível de qualidade

Agency

traceable to Ph. Eur. A1202000
traceable to USP 1134368

família API

citric acid

Certificado de análise (CofA)

current certificate can be downloaded

Lim. expl.

8 %, 65 °F

técnica(s)

HPLC: suitable
gas chromatography (GC): suitable

pKa 

(1) 3.13, (2) 4.76, (3) 6.4

pf

153-159 °C (lit.)

aplicação(ões)

pharmaceutical (small molecule)

Formato

neat

temperatura de armazenamento

2-30°C

cadeia de caracteres SMILES

OC(=O)CC(O)(CC(O)=O)C(O)=O

InChI

1S/C6H8O7/c7-3(8)1-6(13,5(11)12)2-4(9)10/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)

chave InChI

KRKNYBCHXYNGOX-UHFFFAOYSA-N

Procurando produtos similares? Visita Guia de comparação de produtos

Descrição geral

Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Citric acid is a common ingredient in pharmaceutical formulations. It finds use in antacids and dentrifices because of the effervescent effect it generates upon combination with carbonates or bicarbonates. Citric acid may also be used as a buffering agent and it assists in the dispersion of suspensions in order to ensure the stability of the active ingredients and enhance the efficacy of antioxidants.[1]

Aplicação

Anhydrous citric acid may be used as a reference standard in determining the concentration of citric acid present in biological fluids using spectrophotometric method.[2]
Citric acid, Anhydrous may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical formulations[1][3][4] and milk samples[4] by various chromatography techniques.
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.

Nota de análise

These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available.

Outras notas

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

Nota de rodapé

To see an example of a Certificate of Analysis for this material enter LRAB7603 in the slot below. This is an example certificate only and may not be the lot that you receive.

Produtos recomendados

Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.

Pictogramas

Exclamation mark

Palavra indicadora

Warning

Frases de perigo

Classificações de perigo

Eye Irrit. 2 - STOT SE 3

Órgãos-alvo

Respiratory system

Código de classe de armazenamento

11 - Combustible Solids

Classe de risco de água (WGK)

WGK 1

Ponto de fulgor (°F)

Not applicable

Ponto de fulgor (°C)

Not applicable


Certificados de análise (COA)

Busque Certificados de análise (COA) digitando o Número do Lote do produto. Os números de lote e remessa podem ser encontrados no rótulo de um produto após a palavra “Lot” ou “Batch”.

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Os clientes também visualizaram

Slide 1 of 6

1 of 6

Ácido cítrico anhydrous powder, EMPROVE® EXPERT, Ph. Eur., BP, ChP, JP, USP

SAFC

1.37002

Ácido cítrico

Ácido cítrico 99%

Sigma-Aldrich

C0759

Ácido cítrico

Ácido cítrico ACS reagent, ≥99.0%

Sigma-Aldrich

C1909

Ácido cítrico

Malic acid Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1273

Malic acid

Ácido cítrico BioUltra, anhydrous, ≥99.5% (T)

Sigma-Aldrich

27487

Ácido cítrico

Ácido cítrico anhydrous fine-granular, EMPROVE® ESSENTIAL, Ph. Eur., BP, ChP, JP, USP, FCC, E 330

SAFC

1.00247

Ácido cítrico

High performance liquid chromatography method for determination of methyl-5-benzoyl-2-benzimidazole carbamate (mebendazole) and its main degradation product in pharmaceutical dosage forms
Al-Kurdi Z, et al.
Talanta, 50(5), 1089-1097 (1999)
A simplified photometric method for the determination of citric acid in biological fluids
Ettinger.HR, et al.
The Journal of Biological Chemistry, 199(2), 531-536 (1952)
Development and validation of an assay for citric acid/citrate and phosphate in pharmaceutical dosage forms using ion chromatography with suppressed conductivity detection
DeBorba BM, et al.
Journal of Pharmaceutical and Biomedical Analysis, 36(3), 517-524 (2004)
Liquid chromatographic determination with fluorescence detection of B6 vitamers and riboflavin in milk and pharmaceuticals
Gatti R and Gioia MG
Analytica Chimica Acta, 538(1-2), 135-141 (2005)
Wayne B Batchelor et al.
Circulation, 106(12), 1470-1476 (2002-09-18)
The relative anti-aggregatory effects of currently prescribed platelet glycoprotein IIb/IIIa receptor antagonists during and after percutaneous coronary intervention for acute coronary syndromes have not been established. We randomized 70 acute coronary syndrome patients undergoing percutaneous coronary intervention to receive abciximab

Protocolos

Science Slam panel: Leading gene therapy developers discuss commercialization challenges and the importance of robust process development plans.

Questions

Reviews

No rating value

Active Filters

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica